2013-10-08 11:24:25 - New Healthcare research report from Business Monitor International is now available from Fast Market Research
While Sri Lanka's negative pharmaceutical trade balance is expected to widen over the next five years, we are encouraged by the government's focus on increasing local production of medicines, both on a national level and by inviting foreign investment. The vast majority of imported medicines come from neighbouring India. However, a number of Indian companies have in recent months been found to be in breach of regulations and subsequently denied importing rights, which will affect the level of imports.
Headline Expenditure Projections
* Pharmaceuticals: LKR59.86bn (US$469mn) in 2012 to LKR67.77bn (US$524mn) in 2013; +13.2% in local currency terms and +11.8% in US dollar terms.
* Healthcare: LKR252.10bn (US$1.98bn) in 2012 to LKR281.89bn (US$2.18bn) in 2013; +11.8% in local currency terms and
10.4% in US dollar terms.
Full Report Details at
- www.fastmr.com/prod/689051_sri_lanka_pharmaceuticals_healthcare_ ..
According to our Q413 regional matrix, with a score of 39 out of 100.0 Sri Lanka is ranked 17th out of the 18 markets surveyed - above Cambodia and below Bangladesh. Sri Lanka's rewards and risks profiles are relatively evenly balanced, Low per capita expenditure on drugs and the modest overall market size are two of the key factors contributing to its low ranking.
Key Trends And Developments
In September 2013, the World Bank signed a loan agreement to provide a US$200mn loan to the Sri Lankan health sector, according to country's finance and planning ministry. The loan will fund measures to fight malnutrition; the prevention and control of non-communicable diseases; the promotion of maternal and child health; and to improve country's overall healthcare system. The World Bank finance will aid the Sri Lankan government's total budgetary requirement for the ongoing five-year health programme valued at US $5,170mn.
In October 2013, four Indian companies were banned from supplying medicines to Sri Lanka - after being faulted for supplying low-quality medicines to the country for a period of four years. BMI Political View: The strategic space for Sino-Lanka ties to continue strengthening should remain wide, if not become even wider, due to the ongoing friction between Sri Lanka and India. Stronger ties with China could greatly enhance the already extensive positive economic spillovers this relationship has bestowed from the island's perspective. In this article, we briefly flesh out the recent developments in this key economic partnership.
BMI Economic View: In line with our expectations for Sri Lanka to register renewed weakness through H113, the GDP figures for Q113 showed real growth softening to 6.0% year-on-year (y-o-y) from 6.3% in Q412. While the bottoming out in growth of the key services sector bodes well for our expectation for a sustained recovery from H213 onwards, with our full-year growth forecast at 6.4%, we believe that such an upturn is unlikely to be a forceful one.
Report Table of Contents:
BMI Industry View
- BMI Industry View
- Business Environment
- Pharmaceutical Market Forecast
- Table: Sri Lanka Pharmaceutical Sales, Historical Data And Forecasts
- Healthcare Market Forecast
- Table: Sri Lanka Healthcare Expenditure Trends, Historical Data And Forecasts
- Table: Sri Lanka Government Healthcare Expenditure Trends, Historical Data And Forecasts
- Table: Sri Lanka Private Healthcare Expenditure Trends, Historical Data And Forecasts
- Prescription Drug Market Forecast
- Pharmaceutical Trade Forecast
- Table: Sri Lanka Pharmaceutical Trade Data And Forecasts (US$mn)
- Table: Sri Lanka Pharmaceutical Trade Data And Forecasts (LKRmn)
- Other Healthcare Data
- Key Risks To BMI's Forecast Scenario
- Economic Analysis
- Table: SRI LANKA - ECONOMIC ACTIVITY
Industry Risk Reward Ratings
- Asia Pacific Risk/Reward Ratings
- Sri Lanka Risk/Reward Ratings
- Market Overview
Industry Trends And Developments
- Industry Trends And Developments
- Healthcare System
- Hospital Sector
- Healthcare Financing
- Clinical Trials
- Regulatory Regime
- Regulatory Developments
- Pricing And Reimbursement Regimes
- Pricing And Reimbursement Developments
- Supply Chain
- Competitive Landscape
- Pharmaceutical Industry
- Table: Local Drug Manufacturers
- Pharmaceutical Industry Developments
- Pharmaceutical Distribution And Retail
- State Pharmaceuticals Corporation (SPC)
- Hemas Holdings
- Table: Sri Lanka's Population By Age Group, 1990-2020 ('000)
- Table: Sri Lanka's Population By Age Group, 1990-2020 (% of total)
- Table: Sri Lanka's Key Population Ratios, 1990-2020
- Table: Sri Lanka's Rural And Urban Population, 1990-2020
About Business Monitor International
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.